GlassScriptPhysician profile
Rahul Pawar
NPI 1639455090
$604.43
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.72 · 2020: $59.46 · 2021: $206 · 2022: $132 · 2023: $51.87 · 2024: $83.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $211.68 | 2022-2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $134.92 | 2019-2022 | |
| Glaxosmithkline, LLC. | $64.14 | 2021 | |
| Amgen INC. | $46.95 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.46 | 2023 | Gattex |
| Horizon Therapeutics Plc | $30.28 | 2021 | |
| Pfizer INC. | $26.87 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $21.55 | 2021 | |
| Biogen, INC. | $16.38 | 2021 | |
| Fresenius USA Marketing, INC. | $15.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Pawar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.